More PYC Therapeutics Limited news
PYC Therapeutics LimitedASX: PYC

S&P DJI Announces September 2026 Quarterly Rebalance

Sep 4, 2026 at 3:31 AM EDT · Issued by PYC Therapeutics Limited

Filed with ASX · Sep 4, 2026 at 3:31 AM EDT · 6 pages · English

On 6ix: 6ix.com/news/sandp-dji-announces-september-2026-quarterly-rebalance-7

PYC Therapeutics Limited on 6ix

In the deck

  • PYC Therapeutics — Investor Presentation (September 2026)17 slidesSep 4, 2026

Earlier from PYC Therapeutics

  • Investor Webinar Presentation Q3 2026Sep 3
  • ADOA Program - Data PresentationSep 2
  • Ceasing to be a substantial holderSep 2
  • PKD - Presentation of Clinical Safety DataAug 30
  • 2026 Corporate Governance StatementAug 28

Later from PYC Therapeutics

  • PKD - First Patient Dosed in OLE StudySep 10
  • RP11 program - presentation at Euretina 2026Oct 1
  • PKD Program - Presentation of Data at ASN ConferenceOct 6
  • Notification of cessation of securities - PYCOct 7
  • Application for quotation of securities - PYCOct 7
All PYC Therapeutics news releases↗

Follow PYC Therapeutics into a list and get an email when it puts out news.

Follow PYC Therapeutics
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer